Exit: Practica Capital's portfolio company, Oxipit, has been acquired by Sectra
Oxipit, a Lithuanian startup specialising in AI-based solutions for radiology, will be acquired by Sectra, an international medical imaging IT and cybersecurity company. Oxipit holds the first CE Class IIB certification for autonomous AI in chest X-ray analysis.
Oxipit's ChestLink is a leading example of this autonomous approach. Within its defined clinical scope, it automatically identifies and clears high-confidence normal chest X-ray examinations from the radiologist's worklist. This allows radiologists to focus their expertise on cases with a higher probability of disease.
The Oxipit team will operate as a dedicated AI development centre within Sectra's Imaging IT Solutions operating area. Alongside Sectra's own capabilities, Sectra's Amplifier service will remain an open, vendor-neutral ecosystem, providing healthcare providers access to AI applications from a wide range of vetted partners.
Oxipit was founded in 2017 and has developed a portfolio of CE-marked AI solutions for radiology spanning chest X-ray, CT, and musculoskeletal imaging. The solutions are currently deployed across multiple markets internationally.
The Practica Capital team, commenting on the exit on LinkedIn, said: "From an idea at a hackathon tackling radiologist shortage and improving patient care, to the world's first fully autonomous AI medical imaging application. As first investors in 2019, we had a front-row seat to the entire Oxipit journey. Thank you for the perseverance and congratulations to the founding and managing team — Peter, Vytautas, Gediminas, Jonas, Naglis, Darius, Jogundas. It has been a great pleasure to work with you."
The acquisition will be financed using Sectra's own funds and comprises an upfront cash consideration and an additional contingent consideration linked to commercial and regulatory milestones. Financial terms are not disclosed. The transaction is subject to customary closing conditions and is expected to be completed during March 2026.
